Cancer trials: Search results
Results: 16 items found.
Refine results
AGIOS A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of AG-881 in Subjects with Residual or Recurrent Grade 2 Glioma with an IDH1 or IDH2 Mutation
Trial short name: AGIOS
Cancer type: Central Nervous System
Cancer location: Brain
Disease stage: Early Cancer
Trial phase: Phase 3
Imaging biomarker for differentiating of radiation necrosis from tumour progression in brain metastasis treated with stereotactic radiosurgery
Trial short name: CEST Necrosis
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Other
Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD
Trial short name: CLIMB LMD
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 2
Assessing the Feasibility and Impact of Providing Dignity Therapy to Patients With Recurrent and/or Progressed Primary Malignant Brain Tumours and Their Family Caregivers in an Adult Ambulatory Oncology Care Setting
Trial short name: Dignity Therapy
Cancer type: Central Nervous System
Cancer location: Brain
Disease stage: Advanced Cancer
Trial phase: Other
A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations
Trial short name: F8394-201
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 2
An International, Seamless Phase II/III Responsive Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Trial short name: GBM AGILE
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 3
Magnetic resonance imaging as a tool to adapt concurrent chemoradiation treatment for malignant gliomas
Trial short name: GBMSM1
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Other
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
Trial short name: IMbrave152
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 3
Molecular, Imaging, and Neurological assessment Database for CNS tumours
Trial short name: MIND-CNS
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Other
The Multiple OutcoMe EvaluatioN of radiation Therapy Using the MR-linac Study
Trial short name: MOMENTUM
Cancer type: Central Nervous System
Cancer location: Other (Central Nervous System)
Disease stage: Other
Trial phase: Other
Metastatic Tumor Research and Outcomes Network
Trial short name: MTRON
Cancer type: Central Nervous System
Cancer location: Spine
Disease stage: Advanced Cancer
Trial phase: Other
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Trial short name: ONC201-108
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 3
qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia
Trial short name: qBOLD in MRI
Cancer type: Central Nervous System
Cancer location: Brain
Disease stage: Early and Advanced Cancer
Trial phase: Other
EF-32 (TRIDENT): A PIVOTAL RANDOMIZED, OPEN-LABEL STUDY OF OPTUNE® (TTFIELDS, 200KHZ) CONCOMITANT WITH RADIATION THERAPY AND TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA
Trial short name: Trident EF-32
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase:
UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: A Phase 2 Trial (UNITED trial)
Trial short name: UNITED
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 2
UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionationed Boost Trial for High Grade Glioma in the Elderly
Trial short name: UNITED2
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 2
